9 USD
-0.01 (-0.11%)
9 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 10.82. This target is 20.23% above the current price.
- EPRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EPRX.
- In the previous month the buy percentage consensus was at a similar level.
- EPRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-06-26 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
EUPRAXIA PHARMACEUTICALS INC / EPRX FAQ
Can you provide the average price target for EUPRAXIA PHARMACEUTICALS INC stock?
8 analysts have analysed EPRX and the average price target is 10.82 USD. This implies a price increase of 20.23% is expected in the next year compared to the current price of 9.
What is the consensus rating for EPRX stock?
The consensus rating for EUPRAXIA PHARMACEUTICALS INC (EPRX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover EUPRAXIA PHARMACEUTICALS INC (EPRX) stock?
The number of analysts covering EUPRAXIA PHARMACEUTICALS INC (EPRX) is 8.